The companys expertise in isolating, characterizing, and synthesizing biologically active peptides from natural venom sources positioned it uniquely to identify and optimize the Waglerin-1-mimetic structure that became Syn-AKE
Slowly inject the water down the wall of the vial
FDA reviewers, applying the statutory framework under 21 CFR 216.23(c), identified only one human study for BPC-157's proposed indication of ulcerative colitis: a decades-old meeting abstract that was never published as a peer-reviewed trial and that used an oral route of administration not the injectable or subcutaneous routes that wellness clinics commonly use
Research into BPC-157 peptide highlights its significant biological effects, which may include expedited recovery from injuries, support for chronic conditions, and potential management of inflammatory diseases
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept
Can B12 injections be combined with other treatments
